Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
Clinical trial NCT03520231 · COMPLETED
Trial details
- NCT number
- NCT03520231
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-04
- Primary completion
- 2020-12-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.